Metabolomics & Pharmacology

Pharmacogenomics has some impact in clinical practice, through its use to select patient subgroups who will enjoy efficacy without side effects when treated with certain drugs. However, pharmacogenomics, has had less impact than initially predicted. One reason for this is that many diseases, and the way in which the patients respond to drug treatments, have both genetic and environmental elements. Pure genomics is almost blind to the environmental elements. A new methodology has emerged, termed pharmacometabolomics that is concerned with the prediction of drug effects through the analysis of pre-dose, biofluid metabolite profiles, which reflect both genetic and environmental influences on human physiology. 

  • Implications of Clinical Pharmacology
  • Pharmaceutical research & Metabolomics in the New born

Related Conference of Metabolomics & Pharmacology

September 18-18, 2020

9th World Congress on Glycobiology & Glycochemistry

Dubai, UAE
September 22-23, 2020

International Conference on Nucleic Acids

Dubai, UAE
September 28-29, 2020

2nd International Conference on Metabolomics, Genomics and Proteomics

Singapore City, Singapore
September 28-29, 2020

19th International Conference on Structural Biology

Barcelona, Spain
September 29-30, 2020

World Congress on Biosensors and Bioelectronics

Osaka, Japan
October 21-22, 2020

18th International Conference on Metabolomics and Proteomics

Frankfurt, Germany
December 10-11, 2020

2nd Pathology and Infectious Disease Conference

Dubai, UAE
March 18-19, 2021

12th Tissue Repair and Regeneration Congress

Abu Dhabi, UAE
March 28-29, 2021

11th Glycobiology World Congress

Vienna, Austria
September 13-14, 2021

17th World Congress on Structural Biology

Prague, Czech Republic

Metabolomics & Pharmacology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in